GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Genomma Lab Internacional SAB de CV (MEX:LABB) » Definitions » Shiller PE Ratio

Genomma Lab InternacionalB de CV (MEX:LABB) Shiller PE Ratio : 20.04 (As of Jun. 25, 2024)


View and export this data going back to 2008. Start your Free Trial

What is Genomma Lab InternacionalB de CV Shiller PE Ratio?

As of today (2024-06-25), Genomma Lab InternacionalB de CV's current share price is MXN16.63. Genomma Lab InternacionalB de CV's E10 for the quarter that ended in Mar. 2024 was MXN0.83. Genomma Lab InternacionalB de CV's Shiller PE Ratio for today is 20.04.

The historical rank and industry rank for Genomma Lab InternacionalB de CV's Shiller PE Ratio or its related term are showing as below:

MEX:LABB' s Shiller PE Ratio Range Over the Past 10 Years
Min: 9.31   Med: 19.98   Max: 36.27
Current: 20.01

During the past years, Genomma Lab InternacionalB de CV's highest Shiller PE Ratio was 36.27. The lowest was 9.31. And the median was 19.98.

MEX:LABB's Shiller PE Ratio is ranked better than
58.88% of 535 companies
in the Drug Manufacturers industry
Industry Median: 23.79 vs MEX:LABB: 20.01

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Genomma Lab InternacionalB de CV's adjusted earnings per share data for the three months ended in Mar. 2024 was MXN0.360. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is MXN0.83 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Genomma Lab InternacionalB de CV Shiller PE Ratio Historical Data

The historical data trend for Genomma Lab InternacionalB de CV's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genomma Lab InternacionalB de CV Shiller PE Ratio Chart

Genomma Lab InternacionalB de CV Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 20.85 20.73 23.72 18.35 17.49

Genomma Lab InternacionalB de CV Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15.30 13.98 14.47 17.49 18.88

Competitive Comparison of Genomma Lab InternacionalB de CV's Shiller PE Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Genomma Lab InternacionalB de CV's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Genomma Lab InternacionalB de CV's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Genomma Lab InternacionalB de CV's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Genomma Lab InternacionalB de CV's Shiller PE Ratio falls into.



Genomma Lab InternacionalB de CV Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Genomma Lab InternacionalB de CV's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=16.63/0.83
=20.04

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Genomma Lab InternacionalB de CV's E10 for the quarter that ended in Mar. 2024 is calculated as:

For example, Genomma Lab InternacionalB de CV's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.36/152.9470*152.9470
=0.360

Current CPI (Mar. 2024) = 152.9470.

Genomma Lab InternacionalB de CV Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201406 0.290 96.609 0.459
201409 0.450 97.652 0.705
201412 0.480 99.469 0.738
201503 0.130 99.973 0.199
201506 0.340 99.382 0.523
201509 0.179 100.112 0.273
201512 -1.690 101.588 -2.544
201603 0.343 102.573 0.511
201606 -2.423 101.905 -3.637
201609 0.461 103.084 0.684
201612 0.020 105.002 0.029
201703 0.417 108.063 0.590
201706 0.261 108.339 0.368
201709 0.220 109.628 0.307
201712 0.323 112.114 0.441
201803 0.358 113.505 0.482
201806 0.290 113.373 0.391
201809 0.213 115.130 0.283
201812 0.202 117.530 0.263
201903 0.241 118.050 0.312
201906 0.232 117.848 0.301
201909 0.223 118.581 0.288
201912 0.020 120.854 0.025
202003 0.367 121.885 0.461
202006 0.355 121.777 0.446
202009 0.402 123.341 0.498
202012 0.255 124.661 0.313
202103 0.314 127.574 0.376
202106 0.373 128.936 0.442
202109 0.386 130.742 0.452
202112 0.215 133.830 0.246
202203 0.338 137.082 0.377
202206 0.403 139.233 0.443
202209 0.398 142.116 0.428
202212 0.319 144.291 0.338
202303 0.340 146.472 0.355
202306 0.433 146.272 0.453
202309 0.384 148.446 0.396
202312 -0.065 151.017 -0.066
202403 0.360 152.947 0.360

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Genomma Lab InternacionalB de CV  (MEX:LABB) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Genomma Lab InternacionalB de CV Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Genomma Lab InternacionalB de CV's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Genomma Lab InternacionalB de CV (MEX:LABB) Business Description

Traded in Other Exchanges
Address
Avenida Antonio Dovalí Jaime, Number 70, Tower C, Floor 2, Office A. Colonia Santa Fe, Del. Alvaro Obregon, Mexico, MEX, MEX, CP 01210
Genomma Lab Internacional SAB de CV is a specialty and generic drug manufacturer. The company's stated goal is to improve and preserve the health and well-being of people through innovative, safe, and effective products. Genomma operates a wide variety of brands to serve different consumer needs, including pregnancy, pain medication, and deodorant. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Genomma Lab InternacionalB de CV (MEX:LABB) Headlines

No Headlines